Physician profile
Joseph E Broyles
NPI 1609864008
$1,091.30
in general payments reported to CMS, 2019-2025
9 companies · $58.34 in 2025
The $58.34 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $81.41 · 2021: $118 · 2022: $226 · 2024: $227 · 2025: $58.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $285.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microport Orthopedics INC | $283.28 | 2019-2022 | |
| Stryker Corporation | $244.32 | 2019-2020 | |
| Maxx Orthopedics, INC. | $149.89 | 2024 | |
| Zimmer Biomet Holdings, INC. | $147.29 | 2021-2022 | |
| Medacta USA, INC. | $98.25 | 2022 | |
| Linkbio Corp | $77.51 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $58.34 | 2025 | |
| Corin USA | $20.17 | 2019 | |
| Boston Scientific Corporation | $12.25 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Broyles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.